Stockreport

Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones [Yahoo! Finance]

Relay Therapeutics, Inc.  (RLAY) 
PDF Relay Therapeutics, Inc. Initial Phase 1 data of zovegalisib in PIK3CA-driven vascular anomalies expected to be announced in first half of 2026 Breast cancer triple [Read more]